{"title": "Moderna - Wikipedia", "author": "Authority control ISNI", "url": "https://en.wikipedia.org/wiki/Moderna", "hostname": "wikipedia.org", "description": null, "sitename": "Wikimedia Foundation, Inc.", "date": "2013-06-21", "cleaned_text": "Massachusetts](/wiki/Cambridge,_Massachusetts), that focuses on [RNA therapeutics](/wiki/RNA_therapeutics), primarily [mRNA vaccines](/wiki/MRNA_vaccine). These [vaccines](/wiki/Vaccine) use a copy of a molecule called [messenger RNA](/wiki/Messenger_RNA) (mRNA) to carry instructions for proteins to produce an [immune response](/wiki/Immune_response). [[5]](#cite_note-5) [[1]](#cite_note-10K-1) The company's name and \"modern\". [[6]](#cite_note-moderna-about-6) [[7]](#cite_note-stat-story-7) [[8]](#cite_note-servick-8) is the [Moderna COVID-19 vaccine](/wiki/Moderna_COVID-19_vaccine), marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered [clinical trials](/wiki/Clinical_trial). Candidates include [Zika virus vaccine](/wiki/Zika_virus_vaccine) funded by the [Biomedical Advanced Research and Development Authority](/wiki/Biomedical_Advanced_Research_and_Development_Authority), and three [cancer vaccines](/wiki/Cancer_vaccine). The company's [acute decompensated heart includes medicine](/wiki/Regenerative_medicine) treatment that factor Bancel](/wiki/St%C3%A9phane_Bancel), CEO, was appointed as CEO in 2011. [[6]](#cite_note-moderna-about-6) [[10]](#cite_note-Ego-10) Between 2011 and 2017, Product development[ [edit](/w/index.php?title=Moderna&action=edit\u00a7ion=2)] In 2013, the company formed a partnership with [AstraZeneca](/wiki/AstraZeneca) to develop treatments for cardiovascular, metabolic, and renal diseases, as well as cancer. In January 2014, the company entered an agreement with [Alexion Pharmaceuticals](/wiki/Alexion_Pharmaceuticals) to develop treatments against ten diseases. [[11]](#cite_note-11) On January 14, 2014, Moderna announced the creation of its first spinoff company, Onkaido Therapeutics, to focus \"exclusively on developing mRNA-based [[13]](#cite_note-13) It launched its second spinoff, Valera, in January 2015, with a focus on \"viral, bacterial and parasitic infectious diseases.\" [[14]](#cite_note-14) [[15]](#cite_note-15) Employees of Valera and Moderna would go on to develop an mRNA vaccine candidate against [Zika virus](/wiki/Zika_virus) infection. [[16]](#cite_note-16) Another spinoff, Elpidera, was announced in May 2015 to continue work on RNA therapies advancing Moderna's work with Alexion. [[17]](#cite_note-17) [[18]](#cite_note-18) In 2015, the company formed a partnership with [Merck & Co.](/wiki/Merck_%26_Co.) to develop treatments for cancer, and in 2016 the company formed a partnership with [Vertex Pharmaceuticals](/wiki/Vertex_Pharmaceuticals) to develop treatments for [cystic In January 2016, the [Bill & Melinda Gates Foundation](/wiki/Bill_%26_Melinda_Gates_Foundation) committed to provide at least $20 million in [grant](/wiki/Grant_(money)) funding to the company. [[1]](#cite_note-10K-1) In July 2018, the company opened a 200,000 square foot facility in [Norwood, Massachusetts](/wiki/Norwood,_Massachusetts) for manufacturing, preclinical and clinical work. [[6]](#cite_note-moderna-about-6) [[22]](#cite_note-22) In December 2018, Moderna became a [public company](/wiki/Public_company) via the largest [initial public offering](/wiki/Initial_public_offering) of a biotechnology company in history, raising $621 million by selling 27 million shares at $23 per share. [[23]](#cite_note-23) [[24]](#cite_note-24) The first mRNA vaccine developed by Moderna was for [influenza](/wiki/Influenza) in 2015, and its first [antibody](/wiki/Antibody) encoded by mRNA was in 2019. [[6]](#cite_note-moderna-about-6) In 2023, Moderna acquired OriCiro Genomics, a Japanese manufacturer of [genetic engineering](/wiki/Genetic_engineering) tools, in its first acquisition. [[25]](#cite_note-25) In early 2023, the company in collaboration with [Merck](/wiki/Merck_%26_Co.) won [breakthrough status](/wiki/Breakthrough_therapy) from the FDA for its [mRNA-4157/V940](/wiki/MRNA-4157/V940) drug candidate, a [cancer vaccine](/wiki/Cancer_vaccine). [[26]](#cite_note-natmed1-26) [[27]](#cite_note-27) On 5 July 2023, the company announced that it entered an agreement with the Chinese government to develop mRNA drugs for exclusive use in the PRC despite political tensions between the two nations. The development of new products \"would address the growing need by China to supply effective drugs to its aging population with higher rates of chronic diseases and health concerns stemming from an increasingly westernised diet\", according to the statement. [[28]](#cite_note-28) COVID-19 vaccine[ [edit](/w/index.php?title=Moderna&action=edit\u00a7ion=3)] 2020 to 2021, Moderna received $955 million from [Operation Warp Speed](/wiki/Operation_Warp_Speed) to accelerate development of its COVID-19 vaccine, with $4.9 billion committed in total for producing 300 million vaccine doses. [[29]](#cite_note-29) [[30]](#cite_note-30) In March 2020, the [Food and [clinical trials](/wiki/Clinical_trial) for the [Moderna COVID19 vaccine](/wiki/Moderna_COVID%E2%80%9119_vaccine) candidate, and in December, the vaccine, mRNA-1273, was issued an [emergency use authorization](/wiki/Emergency_use_authorization) in the United States. [[31]](#cite_note-31) [[32]](#cite_note-32) In 2022, it gained FDA approval both [monovalent vaccine](/wiki/Vaccine#Valence), Spikevax, and Biopharma](/wiki/Arbutus_Biopharma) and Genevant Sciences filed a lawsuit against Moderna, accusing the company of seven counts of [patent infringement](/wiki/Patent_infringement). [[34]](#cite_note-34) In April 2022, Moderna announced plans to build a $180 million vaccine factory in [Montreal](/wiki/Montreal), forming a 10-year partnership with the [Government of Canada](/wiki/Government_of_Canada), [Quebec](/wiki/Quebec), and [McGill University](/wiki/McGill_University) to produce 100 million Spikevax doses annually and expand vaccine research capabilities. [[35]](#cite_note-35) In August 2022, Moderna sued [Pfizer](/wiki/Pfizer) and [BioNTech](/wiki/BioNTech) in both Massachusetts and Germany, alleging that the [Pfizer-BioNTech COVID-19 vaccine](/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine) violates the patent on Moderna's [mRNA vaccine](/wiki/MRNA_vaccine) technology. [[36]](#cite_note-36) In February 2023, the company agreed to pay $400 million to the [National Institutes of Health](/wiki/National_Institutes_of_Health), [Dartmouth College](/wiki/Dartmouth_College), and [Scripps Research](/wiki/Scripps_Research) to settle a dispute over the rights to a chemical technique that was used in the vaccine. [[37]](#cite_note-37) On March 10, 2023, U.S. District Judge [Mitchell Goldberg](/wiki/Mitchell_Goldberg) rejected a bid by Moderna to dismiss some of the patent infringement claims brought against the company by Arbutus Biopharma and Genevant Inc. Schedule 14A 2021 [YouTube](/wiki/YouTube). [^](#cite_ref-5)Park X, Aikins ME, Moon JJ (December 2020). [\"Non-viral COVID-19 vaccine delivery systems\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744276). Advanced big moments\"](https://www.modernatx.com/en-US/about-us/our-story). February 10, 2023. - ^ [a](#cite_ref-stat-story_7-0) [b](#cite_ref-stat-story_7-1)Garde, Damian; Saltzman, Jonathan (November 10, 2020). [\"The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race\"](https://www.statnews.com/2020/11/10/the-story-of-mrna-how-a-once-dismissed-idea-became-a-leading-technology-in-the-covid-vaccine-race/). [Stat](/wiki/Stat_(website)). [Archived](https://web.archive.org/web/20201110183905/https://www.statnews.com/2020/11/10/the-story-of-mrna-how-a-once-dismissed-idea-became-a-leading-technology-in-the-covid-vaccine-race/)from the original on November 10, 2020. - ^ [a](#cite_ref-servick_8-0) [b](#cite_ref-servick_8-1)Servick, Kelly (March 25, 2020). [\"This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines (from the original, 1 February 2017)\"](https://www.science.org/content/article/mysterious-2-billion-biotech-revealing-secrets-behind-its-new-drugs-and-vaccines). Science. [doi](/wiki/Doi_(identifier)): [10.1126/science.aal0686](https://doi.org/10.1126%2Fscience.aal0686). [S2CID](/wiki/S2CID_(identifier)) [241466550](https://api.semanticscholar.org/CorpusID:241466550). Thing\"](https://www.bostonmagazine.com/health/2013/02/26/moderna-therapeutics-new-medical-technology/). [Boston Magazine](/wiki/Boston_Magazine). [Archived](https://web.archive.org/web/20201116154152/https://www.bostonmagazine.com/health/2013/02/26/moderna-therapeutics-new-medical-technology/)from the original on November 16, 2020. - ^ [a](#cite_ref-Ego_10-0) [b](#cite_ref-Ego_10-1)Garde, Damien (September 13, 2016). [\"Ego, ambition, and one of biotech's most secretive startups\"](https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/). [Stat](/wiki/Stat_(website)). [Archived](https://web.archive.org/web/20201116154313/https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/)from the original on November 16, 2020. [^](#cite_ref-11)Reidy, Chris (January 13, 2014). [\"Alexion, Moderna announce agreement to develop messenger RNA therapeutics\"](https://www.boston.com/news/innovation/2014/01/13/alexion-moderna-announce-agreement-to-develop-messenger-rna-therapeutics/). [Boston Globe Media Partners](/wiki/Boston_Globe_Media_Partners). [Archived](http://archive.today/2021.07.02-151040/https://www.boston.com/news/innovation/2014/01/13/alexion-moderna-announce-agreement-to-develop-messenger-rna-therapeutics/)from the original on July 2, 2021. Retrieved June 5, 2023. [^](#cite_ref-12)Favorito, Maria (January 14, 2014). [\"Moderna Launches Onkaido Therapeutics to Focus on the Development of with $20 Million Capital Commitment\"](https://web.archive.org/web/20161120035524/http://www.modernatx.com/news-events/press-releases/moderna-launches-onkaido-therapeutics-focus-development-mrna-therapeuticstm). Moderna Therapeutics. Archived from the original on November 20, 2016. Retrieved June 5, 2023. {{: CS1 maint: unfit URL 5, 2023. Retrieved June 5, 2023. [^](#cite_ref-14)Favorito, Maria (January 8, 2015). [\"Moderna Launches New Venture Valera LLC for Infectious Diseases\"](https://web.archive.org/web/20161119214315/http://www.modernatx.com/news-events/press-releases/moderna-launches-new-venture-valera-llc-infectious-diseases). Moderna Therapeutics. Archived from the original on November 19, 2016. Retrieved June 5, 2023. {{: Infectious Diseases\"](https://www.bionity.com/en/news/151144/moderna-launches-new-venture-valera-llc-for-infectious-diseases.html). Bionity. January 12, 2015. [Archived](http://archive.today/2023.06.05-165153/https://www.bionity.com/en/news/151144/moderna-launches-new-venture-valera-llc-for-infectious-diseases.html)from the original on June 5, 2023. Retrieved June 5, 2023. [^](#cite_ref-16)Richner, Justin M.; Himansu, Sunny; Dowd, [\"Modified [\"Moderna Launches Third Venture Company Elpidera for Rare Diseases | Moderna Therapeutics\"](https://web.archive.org/web/20161012234942/http://www.modernatx.com/news-events/press-releases/moderna-launches-third-venture-company-elpidera-rare-diseases). Moderna Therapeutics. Archived from the original on October 12, 2016. Retrieved June 5, 2023. {{: medicine\"](https://www.cnbc.com/2015/05/12/moderna-therapeutics-is-trying-to-cure-disease-with-mrna-drugs.html). [CNBC](/wiki/CNBC). [Archived](http://archive.today/2021.04.10-143842/https://www.cnbc.com/2015/05/12/moderna-therapeutics-is-trying-to-cure-disease-with-mrna-drugs.html)from the original on April 10, 2021. Retrieved June 5, 2023. [^](#cite_ref-Globe_19-0)Weisman, Robert (March 21, 2013). [\"Moderna in line for $240m licensing deal\"](https://www.bostonglobe.com/business/2013/03/20/moderna-therapeutics-receive-million-license-its-technology-drug-giant-astrazeneca/VAFlMn2lZaCDZ6A0oyHKSI/story.html). [The Boston Globe](/wiki/The_Boston_Globe). [Archived](https://web.archive.org/web/20201116154149/https://www.bostonglobe.com/business/2013/03/20/moderna-therapeutics-receive-million-license-its-technology-drug-giant-astrazeneca/VAFlMn2lZaCDZ6A0oyHKSI/story.html)from the 16, 2020. [^](#cite_ref-20) [\"Moderna: Strategic collaborators\"](https://www.modernatx.com/partnerships/strategic-collaborators?). Moderna, Inc. 2023. Retrieved February [^](#cite_ref-21) [\"Vertex and Moderna hammer out fibrosis using mRNA technology\"](https://www.biospace.com/article/vertex-and-moderna-hammer-out-315-million-deal-to-treat-cystic-fibrosis-using-mrna-technology-/). July 6, 2016. Retrieved 11, 2023. [^](#cite_ref-22)DeAngelis, Allison (July 17, 2018). [\"Moderna's $110M Norwood site expansion hopes\"](https://www.bizjournals.com/boston/news/2018/07/17/modernas-110m-norwood-site-built-with-expansion.html). [American City Business Journals](/wiki/American_City_Business_Journals). [^](#cite_ref-23)Mukherjee, Sy (December 8, 2018). [\"Moderna Had the Biggest Biotech IPO Ever. Here's What That Says About the Industry's Future\"](https://fortune.com/2018/12/08/moderna-ipo-biotech-future/). [Fortune](/wiki/Fortune_(magazine)). [Archived](https://web.archive.org/web/20201116154242/https://fortune.com/2018/12/08/moderna-ipo-biotech-future/)from the original on November 16, 2020. [^](#cite_ref-24)Ramsey, Lydia (December 7, 2018). [\"Moderna just priced the biggest IPO in biotech history, valuing the startup at $7.5 billion\"](https://www.businessinsider.com/biotech-moderna-prices-initial-public-offering-2018-12). [Business Insider](/wiki/Business_Insider). [Archived](https://web.archive.org/web/20201116154155/https://www.businessinsider.com/biotech-moderna-prices-initial-public-offering-2018-12?r=US&IR=T)from the original on November 16, 2020. [^](#cite_ref-25)Hayden Schmidt (January 5, 2023). [\"Moderna to Buy Japanese Firm OriCiro in Its First-Ever Acquisition\"](https://pharmanewsintel.com/news/moderna-to-buy-japanese-firm-oriciro-in-its-first-ever-acquisition). PharmaNews Intelligence. Retrieved February [^](#cite_ref-natmed1_26-0) [\"Precision medicine meets cancer vaccines\"](https://www.nature.com/articles/s41591-023-02432-2). [Nature Medicine](/wiki/Nature_Medicine). June 16, 2023. Retrieved July 6, 2023. [^](#cite_ref-27)Bafaloukos, Dimitrios. [\"Evolution and Progress of mRNA Vaccines Future Prospects\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057252/). Donato Paolo (July 5, 2023). [\"US biotech Moderna strikes deal to develop mRNA drugs in China\"](https://www.ft.com/content/a9e9bc51-34a9-455c-a7ae-7b9f8c4cb15a). Financial Times. Retrieved July 6, 2023. [^](#cite_ref-29)Valverde, Miriam (November 19, 2020). [\"How Pfizer's and Moderna's COVID-19 vaccines are tied to Operation Warp Speed\"](https://www.politifact.com/article/2020/nov/19/pfizer-moderna-covid-19-vaccines-and-operation-war/). PolitiFact. Retrieved February 12, 2023. [^](#cite_ref-30)Siddalingaiah, Simi V. (March 1, 2021). [\"Operation Warp Speed Contracts for COVID-19 Vaccines and Ancillary Vaccination Materials\"](https://crsreports.congress.gov/product/pdf/IN/IN11560). Congressional Research Service, United States Government. Retrieved February 12, 2023. [^](#cite_ref-31) [\"Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine\"](https://www.nih.gov/news-events/news-releases/statement-nih-barda-fda-emergency-use-authorization-moderna-covid-19-vaccine). [National Institutes of Health](/wiki/National_Institutes_of_Health). December 18, 2020. [^](#cite_ref-32)Ledford, Heidi (December 18, 2020). [\"Moderna COVID vaccine becomes second to get US authorization\"](https://www.nature.com/articles/d41586-020-03593-7). Nature. [doi](/wiki/Doi_(identifier)): [10.1038/d41586-020-03593-7](https://doi.org/10.1038%2Fd41586-020-03593-7). [\"Moderna COVID-19 vaccines\"](https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccines). US Food and Drug Administration. December 15, 2022. Retrieved February 11, 2023. [^](#cite_ref-34)Choi, Joseph (February 28, 2022). [\"Biotech firms allege Moderna hijacked technology to develop COVID-19 vaccine\"](https://thehill.com/policy/healthcare/596114-biotech-firms-allege-moderna-hijacked-technology-to-develop-covid-19/). [The Hill](/wiki/The_Hill_(newspaper)). [Archived](http://archive.today/2022.03.02-223228/https://thehill.com/policy/healthcare/596114-biotech-firms-allege-moderna-hijacked-technology-to-develop-covid-19)from the original on March 2, 2022. Retrieved August 25, 2023. [^](#cite_ref-35) [\"Moderna facility in Montreal area expected to produce 100 million vaccine doses by 2024\"](https://www.cbc.ca/news/canada/montreal/moderna-montreal-facility-mrna-1.6435636). [CBC News](/wiki/CBC_News). April 29, 2022. [^](#cite_ref-36)Robbins, Rebecca; 26, 2022). [\"Moderna Sues Pfizer and BioNTech Over Covid Vaccine Technology\"](https://www.nytimes.com/2022/08/26/business/moderna-covid-vaccine-lawsuit.html). York Times](/wiki/The_New_York_Times). [ISSN](/wiki/ISSN_(identifier)) [0362-4331](https://www.worldcat.org/issn/0362-4331). Retrieved August 26, [^](#cite_ref-37)Mueller, Benjamin (February 23, 2023). [\"After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Technique\"](https://www.nytimes.com/2023/02/23/science/moderna-covid-vaccine-patent-nih.html). [The New York Times](/wiki/The_New_York_Times). [^](#cite_ref-38)Brittain, Blake (March 10, 2023). [\"Moderna loses bid to shift liability in COVID-19 vaccine patent case\"](https://www.reuters.com/legal/moderna-loses-bid-shift-liability-covid-19-vaccine-patent-case-2023-03-10/). [Reuters](/wiki/Reuters). [Archived](http://archive.today/2023.03.11-042647/https://www.reuters.com/legal/moderna-loses-bid-shift-liability-covid-19-vaccine-patent-case-2023-03-10/)from the original on March 11, 2023. Retrieved August 25, 2023. External links[ [edit](/w/index.php?title=Moderna&action=edit\u00a7ion=7)] [Official website](https://www.modernatx.com/) - in 2010](/wiki/Category:American_companies_established_in_2010) [Biotechnology companies of the United States](/wiki/Category:Biotechnology_companies_of_the_United_States) [Biotechnology companies established in 2010](/wiki/Category:Biotechnology_companies_established_in_2010) [Companies based in Cambridge, [COVID-19 "}